Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Huntington Bancshares Incorporated (HBAN) vs Hims and Hers Health Inc (HIMS) Price & Performance

Huntington Bancshares IncorporatedTrade
Hims and Hers Health IncTrade

Price performance (Past 24H)

Key statistics

Huntington Bancshares Incorporated vs Hims and Hers Health Inc — how do they compare? Huntington Bancshares Incorporated trades at $18.12 (market cap $36.62B), while Hims and Hers Health Inc trades at $32.43 (market cap $7.57B). The key difference: Huntington Bancshares Incorporated is far larger — about 4.8× Hims and Hers Health Inc's market cap, and Huntington Bancshares Incorporated pays a 3.43% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.

HBANHIMS
Market Cap
$36.62B$7.57B
Sector
FinancialsHealth
52-Week High
$19.27$66.18
52-Week Low
$15.02$14.52
Dividend Yield
3.43%
Enterprise Value
$7.95B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Huntington Bancshares Incorporated

Huntington Bancshares (HBAN) trades at $18.07, down 0.99% on the day, with a bullish technical signal from moving averages but a neutral reading from oscillators. The company reported Q1 2026 EPS of $0.25, beating expectations, with revenue growth to $8.13 billion in 2025. Recent news highlights expansion in Texas and a strong fintech partnership award.

HBAN presents a mixed outlook; analyst consensus is a Buy with a $20.25 price target, implying upside, but risks include integration challenges from acquisitions and competitive pressures in regional banking. Earnings growth and margin stability are key catalysts, though debt levels have risen steadily.

Hims and Hers Health Inc

Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.

The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.

Returns comparison

Trailing returns across standard periods

About Huntington Bancshares Incorporated

Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.

Read more on HBAN

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS